Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Shares Outstanding (Weighted Average) (2019 - 2025)

Historic Shares Outstanding (Weighted Average) for Harmony Biosciences Holdings (HRMY) over the last 7 years, with Q3 2025 value amounting to $57.7 million.

  • Harmony Biosciences Holdings' Shares Outstanding (Weighted Average) rose 138.04% to $57.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $57.7 million, marking a year-over-year increase of 138.04%. This contributed to the annual value of $56.9 million for FY2024, which is 434.54% down from last year.
  • Latest data reveals that Harmony Biosciences Holdings reported Shares Outstanding (Weighted Average) of $57.7 million as of Q3 2025, which was up 138.04% from $57.5 million recorded in Q2 2025.
  • In the past 5 years, Harmony Biosciences Holdings' Shares Outstanding (Weighted Average) ranged from a high of $60.0 million in Q2 2023 and a low of $56.8 million during Q1 2024
  • Over the past 5 years, Harmony Biosciences Holdings' median Shares Outstanding (Weighted Average) value was $57.7 million (recorded in 2025), while the average stood at $58.1 million.
  • As far as peak fluctuations go, Harmony Biosciences Holdings' Shares Outstanding (Weighted Average) surged by 63025.14% in 2021, and later crashed by 528.86% in 2024.
  • Harmony Biosciences Holdings' Shares Outstanding (Weighted Average) (Quarter) stood at $57.5 million in 2021, then increased by 2.85% to $59.2 million in 2022, then increased by 0.5% to $59.5 million in 2023, then dropped by 4.35% to $56.9 million in 2024, then rose by 1.35% to $57.7 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $57.7 million for Q3 2025, versus $57.5 million for Q2 2025 and $57.3 million for Q1 2025.